Skip to content
Extraction of liquid from scientific funnel
Extraction of liquid from scientific funnel

Life Sciences

Our global Life Sciences team comprises a multi-disciplinary group of professionals, acting for businesses across the pharmaceuticals, biotech, veterinary, consumer health, med tech, and diagnostics sub-sectors.

Our experts advise across the entire product cycle - from product development, clinical trials to market entry, advice on reimbursement claims in Germany and pan-European locations, and post-market pharmacovigilance.

The sector team operates on a cross-border basis and covers the full spectrum of legal support. We advise on mergers and acquisitions, IP (both contentious and non-contentious), regulatory, dispute resolution, commercial transactions (including licensing and collaborations) as well as capital markets and finance.

Our international network ensures that we have a ready resource of expertise in a number of jurisdictions, including those in emerging markets, and that we are in the pole position to advise on cross-border work.

News and insights

image of Anna Wolters-Hoehne

News: 30 November 2023

Allen & Overy boosts IP practice in Germany with hire of Anna Wolters-Höhne

Allen & Overy today announced that renowned life sciences specialist Dr Anna Wolters-Höhne has joined the firm’s intellectual property litigation practice with effect from 1 December 2023. Anna joins…

Read more
Water droplets

Blog Post: 17 July 2023

When is the composition of a product on the market prior art?

G1/23 – EPO Enlarged Board of Appeals of the EPO “available” (referral from T 0438/19) Under which circumstances can the public prior use of a product constitute prior art for novelty or inventive…

Read more
Person picking medicine packet off shelf

Blog Post: 28 November 2022

Webinar - EU developments in pricing and reimbursement

Keeping up with current developments regarding pricing and reimbursement of pharmaceuticals is crucial for planning efficient and successful market access strategies. The regulatory framework…

Read more
Stock information on screen

Publications: 28 July 2022

Equity capital markets in 2022: Europe cools, the Middle East heats up. What next?

The equity capital markets have faced challenging conditions in H1 2022. European markets cooled, the Middle East boomed.

Read more

Life Sciences Talk - Blog

Colour ful image showing medical imagery. Tablets and test tubes shown.

Legal and regulatory developments in the Life Sciences sector.

Download our sector brochure

life sciences and healthcare image

Our Life Sciences and Healthcare sector focus 2023

Our global Life Sciences and Healthcare sector comprises a multi-disciplinary team. We act for companies and their investors across the industry, including in the pharmaceuticals, biotech, animal health, consumer health, medtech, and diagnostics sectors.